1,673 research outputs found
A single machine on-time-in-full scheduling problem
A relevant feature in many production contexts is flexibility. This becomes a key issue, for instance, in the case of third-party cosmetics manufacturing [1]. There, the core business is the production of high quality, fully custom orders in limited batches. Competition is pushing companies to aggressive commercial policies, involving tight delivery dates. At the same time, the custom nature of the orders makes it impossible to keep materials in stock; lead times are always uncertain, often making release dates tight as well, and ultimately yielding unexpected peaks of production loads
Thrombose veineuse profonde : une thrombolyse est-elle efficace ? : revue cochrane pour le praticien
Scénario: Une patiente de 45 ans vous consulte car sa jambe droite est bleue, cyanosée, avec une tension dans le mollet depuis cinq jours, qui s'est étendue progressivement jusqu'au haut de la cuisse. La circonférence du mollet droit est 4 cm plus grande que celle du mollet gauche. La patiente est en surpoids (IMC à 35 kg/m2) et suit depuis quelques années un traitement oestro-progestatif. Elle n'a pas d'anamnèse familiale ou d'antécédent de maladie thromboembolique. Un ultrason montre une thrombose veineuse profonde (TVP) avec un thrombus s'étendant de la veine poplitée à la veine iliaque externe.
Question: La patiente pourrait-elle bénéficier d'une thrombolyse?
Contexte: Les complications de la TVP comprennent l'embolie pulmonaire et le syndrome post-thrombotique. Un syndrome post-thrombotique léger à modéré peut survenir chez 30-50% des patients malgré un traitement anticoagulant, qui prévient principalement l'embolie pulmonaire et la récidive de TVP. Cette mise à jour de revue systématique compare l'efficacité du traitement anticoagulant à celui combinant les anticoagulants et la thrombolyse (par streptokinase, urokinase ou activateur tissulaire du plasminogène)
Thrombolyse bei tiefer Venenthrombose? [Thrombolytic therapy in deep venous thrombosis?]
Sie sehen eine 45-jährige Patientin mit einem bläulich-zyanotischen rechten Bein. Vor fünf Tagen habe ein Spannungsschmerz in der Wade begonnen und sich zunehmend in den Oberschenkel hochgezogen. Die rechte Wade misst im Umfang 4 cm mehr als die linke. Die Anamnese ergibt keine familiäre oder persönliche Vorgeschichte einer thromboembolischen Erkrankung. Die Patientin ist übergewichtig ( BMI 35 kg/m2) und nimmt seit einigen Jahren eine Östrogen-Progesteron-Kombination. Der Ultraschall zeigt eine Thrombose der tiefen Beinvenen, die bis in die äussere Beckenvene reicht
Rare-earth doped glasses and light managing in solar cells
Glasses doped with rare earth elements possess unique photoluminescence properties. They find application in several devices, such as lasers, optical amplifiers, and sensors. More recently, rare-earth doped glass thin films have been the subject of investigation for the development of frequency-converting layers able to increase the efficiency of silicon solar cells. Another approach to the improvement of the performance of a solar cell is based on the capture of a larger flux of light by the detector, which can be obtained by surface texture, plasmonics, or waveguide structures. Here, the recent advances in this area will be briefly reviewed
Assessing the potential of the terrestrial cyanobacterium Anabaena minutissima for controlling Botrytis cinerea on tomato fruits
Cyanobacteria are oxygenic phototrophs that have an essential role in soil N2 fixation, fertility, and water retention. Cyanobacteria are also natural sources of bioactive metabolites beneficial to improve plant vigor and potentially active against fungal plant pathogens. Therefore, we studied the antifungal activity of water extract (WE) and phycobiliproteins (PBPs) from Anabaena minutissima strain BEA 0300B against the fungal plant pathogen Botrytis cinerea on tomato fruits and in vitro. The water extract and PBPs were characterized by using FT-IR and FT-Raman spectroscopies. Both water extract (5 mg/mL) and PBPs (ranged from 0.3 to 4.8 mg/mL) reduced disease incidence and disease severity on tomato fruits and mycelium growth and colony forming units in vitro. For mycelium growth, a linear PBP dose-response was found. Tomato fruits were also characterized by FT-IR and FT-Raman spectroscopies in order to evaluate structural modifications induced by pathogen and PBP treatment. PBPs preserved cutin and pectin structures by pathogen challenge. In conclusion, A. minutissima can be considered a potential tool for future large-scale experiments for plant disease control
- …